SUNSHINE GUOJIAN PHARMACEUTICAL (SH revenue breakdown overview

SUNSHINE GUOJIAN PHARMACEUTICAL (SH revenue for the last year amounted to 1.19 B CNY, the most of which — 1.01 B CNY — came from its highest performing source at the moment, Antibody Drugs, the year earlier bringing 825.49 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SUNSHINE GUOJIAN PHARMACEUTICAL (SH 1.01 B CNY, and the year before that — 794.89 M CNY.